For over 30 years, Biological Industries (BI) – a global leader in cell culture media development, molecular and diagnostic tools, and stem cell research products – has been serving the life sciences industry in more than 50 countries worldwide. Today we are excited to announce Biological Industries USA (BI-USA), a new division headquartered in the United States. Researchers around the country will now have easy, direct access to BI’s entire portfolio of optimized, innovative solutions for general cell culture and stem cell research, as well as access to our dedicated technical experts and collaborations with our R&D scientists. BI offers the leading stem cell culture media NutriStem® – a serum-free; xeno-free stem cell media for the growth and expansion of pluripotent stem cells and mesenchymal stem cells. Bi also offers custom media formulations, products for mycoplasma detection and elimination, cell culture contamination prevention, and human cytogenetics products.
Our state-of-the-art research and manufacturing facilities are cGMP compliant and ISO-certified, with the highest levels of quality management systems in place. It is this level of unmatched commitment to quality along with our strong history of innovation and scientific expertise that defines BI’s culture of excellence.
In this podcast and accompanying article, we talked with Dr. Jennifer Chain, Scientific Director of Research and Development, Oklahoma Blood Institute about isolation of mesenchymal stromal cells from cadaveric bone marrow and the differences between live and cadaveric donors. We also discussed the expansion and maintenance of mesenchymal stromal cells in culture including media design and selection....Continued
Human mesenchymal stem cells (hMSC) are an important tool in regenerative medicine and cell therapies, as they have many attractive cellular characteristics. hMSCs present many advantages for therapeutic applications because they can be sourced from ... Continued